Chemours (CC)
(Delayed Data from NYSE)
$43.99 USD
+0.82 (1.90%)
Updated May 27, 2022 04:00 PM ET
After-Market: $43.98 -0.01 (-0.02%) 5:56 PM ET
2-Buy of 5 2
A Value C Growth C Momentum B VGM
Balance Sheet
Fiscal Year End for The Chemours Company falls in the month of December.
All items in Millions except Per Share data.
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,451 | 1,105 | 943 | 1,201 | 1,556 |
Receivables | 720 | 511 | 674 | 861 | 919 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,099 | 939 | 1,079 | 1,147 | 935 |
Other Current Assets | 75 | 78 | 81 | 84 | 83 |
Total Current Assets | 3,345 | 2,633 | 2,777 | 3,293 | 3,493 |
Net Property & Equipment | 3,154 | 3,474 | 3,559 | 3,291 | 3,008 |
Investments & Advances | 169 | 167 | 162 | 160 | 173 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 108 | 167 | 174 | 181 | 166 |
Deposits & Other Assets | 547 | 405 | 292 | 437 | 453 |
Total Assets | 7,550 | 7,082 | 7,258 | 7,362 | 7,293 |
Liabilities & Shareholders Equity | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1,162 | 844 | 923 | 1,137 | 1,075 |
Current Portion Long-Term Debt | 25 | 21 | 134 | 13 | 15 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 325 | 577 | 484 | 559 | 558 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 346 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,858 | 1,442 | 1,541 | 1,709 | 1,648 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 49 | 36 | 118 | 217 | 208 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 3,724 | 4,005 | 4,026 | 3,959 | 4,097 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 658 | 590 | 633 | 457 | 475 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 6,468 | 6,267 | 6,563 | 6,342 | 6,428 |
Shareholders Equity | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 944 | 890 | 859 | 860 | 837 |
Retained Earnings | 1,746 | 1,303 | 1,249 | 1,466 | 579 |
Other Equity | -363 | -308 | -343 | -558 | -437 |
Treasury Stock | 1,247 | 1,072 | 1,072 | 750 | 116 |
Total Shareholder's Equity | 1,082 | 815 | 695 | 1,020 | 865 |
Total Liabilities & Shareholder's Equity | 7,550 | 7,082 | 7,258 | 7,362 | 7,293 |
Total Common Equity | 1,082 | 815 | 695 | 1,020 | 865 |
Shares Outstanding | 162.96 | 164.50 | 163.50 | 171.00 | 185.10 |
Book Value Per Share | 6.64 | 4.95 | 4.25 | 5.96 | 4.67 |
Fiscal Year End for The Chemours Company falls in the month of December.
All items in Millions except Per Share data.
3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,145 | 1,451 | 1,031 | 1,139 | 1,008 |
Receivables | 1,014 | 720 | 831 | 802 | 723 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,166 | 1,099 | 1,016 | 1,046 | 988 |
Other Current Assets | 68 | 75 | 493 | 60 | 67 |
Total Current Assets | 3,393 | 3,345 | 3,371 | 3,047 | 2,786 |
Net Property & Equipment | 3,131 | 3,154 | 3,127 | 3,448 | 3,432 |
Investments & Advances | 170 | 169 | 190 | 178 | 169 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 107 | 108 | 110 | 162 | 163 |
Deposits & Other Assets | 498 | 547 | 519 | 414 | 392 |
Total Assets | 7,524 | 7,550 | 7,530 | 7,479 | 7,170 |
Liabilities & Shareholders Equity | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1,168 | 1,162 | 1,085 | 1,061 | 976 |
Current Portion Long-Term Debt | 206 | 25 | 25 | 25 | 23 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 302 | 325 | 361 | 321 | 502 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 99 | 346 | 308 | 267 | 0 |
Total Current Liabilities | 1,775 | 1,858 | 1,779 | 1,674 | 1,501 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 52 | 49 | 57 | 55 | 51 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 3,692 | 3,724 | 3,829 | 3,964 | 3,970 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 653 | 690 | 698 | 610 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 6,357 | 6,468 | 6,531 | 6,579 | 6,318 |
Shareholders Equity | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 956 | 944 | 926 | 920 | 907 |
Retained Earnings | 1,940 | 1,746 | 1,554 | 1,381 | 1,357 |
Other Equity | -338 | -363 | -331 | -316 | -342 |
Treasury Stock | 1,393 | 1,247 | 1,152 | 1,087 | 1,072 |
Total Shareholder's Equity | 1,167 | 1,082 | 999 | 900 | 852 |
Total Liabilities & Shareholder's Equity | 7,524 | 7,550 | 7,530 | 7,479 | 7,170 |
Total Common Equity | 1,167 | 1,082 | 999 | 900 | 852 |
Shares Outstanding | 155.47 | 162.96 | 165.10 | 165.10 | 165.50 |
Book Value Per Share | 7.51 | 6.64 | 6.05 | 5.45 | 5.15 |